Expression of Tumor-mediated CD137 ligand in human colon cancer indicates dual signaling effects
CD137-targeting immune therapy, which activates anti-tumor T effector cell responses, seems to be an attractive concept in clinical oncology. Recent evidence has demonstrated that tumor cells besides T cells and antigen-presenting cells are able to express CD137 and CD137L. Here we aimed to identify...
Tallennettuna:
Päätekijät: | , , , , , , , , , , , , , |
---|---|
Aineistotyyppi: | Artigo |
Kieli: | englanti |
Julkaistu: |
2019
|
Linkit: | https://doi.org/10.1080/2162402x.2019.1651622 https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2019.1651622?needAccess=true |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|